Clinical Trials
We are conducting early safety and efficacy trials for vaccines, as well as treatment options and observational studies in the field of infectiology.
Ongoing Trials
- MVA-MERS-S-Phase 1 Vaccine Trial
- SARS-CoV-2-ST Vaccine Trial
- INFLIXCOVID (UK Jena)
- COVID-19 Studies at the UKE
- Nationales Pandemie Kohorten Netz des Netzwerk Universitätsmedizin
- In cooperation with the Bernhardt Nocht Center for Clinical Trails ( BNCCT )
- Pfizer/ Biontech : A Phase 1/2/3, Placebo-Controlled, Randomized, Observer-Blind, Dose-Finding Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals
- Pfizer/ Biontech : A Phase 2b, Open-Label Study to Evaluate Safety, Tolerability & Immunogenicity of BNT162b2 in Immunocompromised Participants ≥2 Years
More information on UKE - Infektionsforschung und Impfstoffentwicklung
